+ Watch LHCG
on My Watchlist
The Company provides post acute healthcare services primarily to Medicare beneficiaries in rural markets in the southern United States.
Here's what Usnzth writes on 12/7/2010:Let's start with a stock that has ROE over 21%, less than 2% debt to capital, and a P/E of 9.Then we have strong management with steady earnings growth in an industry set to explode with the aging baby boomers.Lastly, we have a price drop of over 11% (over $3.00 per share) over the past five days because of a forward earnings adjustment of 10 cents per share.I feel that this solid company has been oversold on a bit of bad news. Yes, the Meidcare reimbursements will drop five percent, but management is telling us this will make - at the most - a 4 percent difference in the bottom line next year.I see no need for such a severe haircut, and bet that this stock will bounce back above $26.00 before the end of January, 2011.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions